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Abstract
Background: Many studies have identified smoking as a risk factor for osteoporosis, but it is unclear whether
passive smoking has an effect on bone mineral density and bone turnover and if such an effect could cause
osteoporosis.The purpose of the study was to investigate the effect of passive smoking on bone mineral density
(BMD) and bone turnover and the relationship between BMD and bone turnover in female rat.
Methods: Forty-eight female Wistar rats were randomized into six groups: 2-month, 3-month,4-month smoke-
exposed rats and their controls. A rat model of passive cigarette smoking was prepared by breeding female rats in
a cigarette-smoking box for 2, 3 or 4 months. Serums were analyzed for levels of osteocalcin, bone-specific alkaline
phosphatase (b-ALP) and Tartrate-resistant acid phosphatase 5b (TRACP 5b). BMD was assessed at lumbar vertebrae
and femur by dual energy X-ray absorptiometry in passive smoking rats and in control rats.
Results: BMD of lumbar spine and femur was lower in 4-month smoke-exposed female rats than that in controls.
However, there was no significant difference in serum osteocalcin levels between smoke-exposed rats and controls.
Significantly lower b-ALP and higher TRACP 5b were found in the 3-month or 4-month smoke-exposed rats
compared to controls. Subsequent analysis showed that b-ALP positively correlated with BMD of the lumbar
vertebrae(r = 0.764, P = 0.027) and femur(r = 0.899, P = 0.002) in 4-month smoke-exposed female rats.
Furthermore, TRACP 5b levels negatively correlated with BMD of lumbar vertebrae (r = -0.871, P = 0.005) and femur
(r = -0.715, P = 0.046) in 4-month smoke-exposed female rats.
Conclusion: Our data suggest that smoke exposure can inhibit bone formation and increase bone resorption. The
hazardous effects of passive smoking on bone status are associated with increased bone turnover in female rat.
Background
Osteoporosis is a chronic, progressive disease of the ske-
leton characterized by bone fragility due to a reduction
in bone mass and possibly alteration in bone architec-
ture which leads to a propensity to fracture with mini-
mum trauma[1]. Many studies found that smoking was
a risk factor for osteoporosis[2-10]. Meta-analyses of the
effects of smoking on bone status have demonstrated
decreased bone mass in current smokers compared to
non-smokers, although data for men was limited[11,12].
Ward et al. [12] reported that the decrease in bone
mass of smokers was greater in men than in women.
Additionally, smoking had more adverse effects on bone
mass for individuals aged 60 years or more [12]. A
review by Wong et al. [6] indicated that effect of smok-
ing on bone mass appeared to be dose-dependent based
on a meta-analysis [12]. Smoking was also associated
with lower areal BMD (bone mineral density) and
reduced cortical thickness in young men [13]. Smoking
cessation, relative to continued smoking, increased BMD
at the femoral trochanter and total hip in postmenopau-
sal women[8].
Cigarette smoking is a worldwide public health pro-
blem. Cigarette smoke is composed of a large variety of
substances, of which nitrogen, oxygen, and carbon diox-
ide account for 85%. Nicotine, which is one of the
addictive components of tobacco, is a highly toxic alka-
loid and has been the focus of several studies evaluating
the relationship between specific cigarette components
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remains controversial, with some studies finding adverse
effects[14,15] and others showing no effects[16,17].
Compared to nicotine treatment alone, cigarette smoke
exposure has been found to be more detrimental to
bone[18], which suggests that cigarette smoke constitu-
ents (e.g., toxic heavy metals, polychlorinated biphenyls,
dioxin, polycyclic aromatic hydrocarbons) other than
nicotine might be responsible for the negative impact of
smoking on bone. The mechanisms by which cigarette
exerted its negative effect on bone are not fully
understood.
There has been recent interest in the use of bone-
turnover markers to evaluate osteoporosis. Bone turn-
over markers can be categorized as bone formation mar-
kers, measured in the serum, or bone resorption
markers, measured in the serum or urine. Compston
[19] showed that older smokers had high levels of bone
resorption while early postmenopausal women had low
levels of bone formation, though the mechanisms had
not been clearly established. At present, the most sensi-
tive markers for bone formation are serum osteocalcin,
Bone-specific alkaline phosphatase (B-ALP) and procol-
lagen type I N-terminal propeptide (PINP). Bone resorp-
tion can be assessed by several biochemical markers, N-
terminal and C-terminal crosslinking telopeptides of
type-I collagen (NTX-I and CTX-I), deoxypyridinoline
( D P D )a n dT R A C P5 b .S e r u mT R A C P5 br e f l e c t st h e
number and activity of osteoclasts on bone surface.
Serum TRACP 5b levels are elevated in patients with
bone diseases and decreased in subjects on antiresorp-
tive treatment, suggesting that serum TRACP 5b is a
specific and sensitive marker of bone resorption[20-22].
It is unclear whether passive smoking has an effect on
BMD and bone turnover, and if such an effect could
cause osteoporosis. We hypothesized that passive smok-
ing may have a negative effect on BMD in female rat by
increasing bone turnover. To provide experimental
proofs for this hypothesis and approach the possible
mechanism of the association between smoking and
osteoporosis, we examine the impact of smoking on
bone turnover and BMD of the femur and lumbar ver-
tebrae in a rat model of passive cigarette smoking. In
this study, bone turnover was assessed by determining
serum osteocalcin and b-ALP for bone formation and
TRACP 5b levels for bone resorption.
Methods
Animals
Forty-eight 6-month-old female Wistar rats about 272 g
were purchased from SLRC Laboratory Animal (Shang-
hai, China). The experiment was performed with the
approval of the Animal Research Committee of the
Xiangya Hospital, and the animals were cared for in the
Experimental Animal Center of Xiangya Hospital.The
rats were acclimated to conditions for one week before
the experiment and randomly assigned to six groups of
8 rats each, three control groups and three smoke-
exposed groups. The smoke-exposed groups were bred
in an environment with smoking for 2, 3 or 4 months.
These rats were housed at 25°C with a 12:12-hour light-
dark cycle and had free access to standard laboratory
food and tap water.
Cigarette Smoking
The rats of passive smoking model were exposed to
Sidestream cigarette smoke(CS) in an ashtray placed 10
cm below the rat cage in an exposure box (30 cm × 5
cm × 15 cm) made of polypropylene, which was placed
in a laboratory draft chamber [23]. Using this equip-
ment, the time, amount, and interval of smoke to be
sent into the chamber was defined, and 10 cigarettes
could be set at a time. The blood concentration of nico-
tine was measured to reflect the intensity of the smok-
ing habit.The contents of the reference research
cigarettes conform to the US Federal Trade Commission
standards. Cigarette smoke was sent for 10 minutes and
then the box was ventilated with room air for 10 min-
utes. This procedure was repeated 10 times at 1-hour
intervals such that the amount of cigarette smoking per
day in the rats was equal to in heavy smokers who
smoke equal to 30 cigarettes per day [24].
Blood nicotine concentrations and baseline bone density
characteristics
The rats were sacrificed by intraperitoneal administration
of sodium pentobarbital after 2, 3 or 4 months, and the
lumbar spine (L4-L6) and both femurs were removed.
Blood was collected from the abdominal vena cava into
heparinized tubes and centrifuged at 1500 r.p.m. and 4°C
for 5 min. Separated plasma was stored at -70°C for sub-
sequent determination of blood nicotine concentrations.
Nicotine concentrations in plasma were measured by gas
chromatography with nitrogen-phosphorus detection.
Sensitivity of the assay was 1 ng/ml nicotine. BMD of
femurs and lumbar vertebrae (L4-L6) were measured by
dual-energy X-ray absorptiometry (DXA; Hologic QDR-
4500A) equipped with appropriate software for bone
assessment in small animals[25]. The coefficients of var-
iations (CV) for repeated measurements on the same
bone was <1.0% for BMD. The results of the BMD in
femur are expressed as the mean value of both femurs.
Similarly to the femur, the results of the BMD in lumbar
spine are expressed as the mean value of L4-L6.
Biomarkers of bone turnover
Venous blood samples were drawn into serum separator
tubes from all subjects. The serum was taken after a
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-70°C until it was assayed. Serum osteocalcin concentra-
tion was measured by an enzyme-linked immunosorbent
assay (Rat Mid™Osteocalcin ELISA kit, IDS Inc., Foun-
tain Hills, AZ, USA) according to the manufacturer’s
instructions. The intra- and inter-assay variations of this
measurement in our laboratory were 6.8% and 8.9%,
respectively. Serum b-ALP was measured by immunoas-
say using the Access Ostase Assay (Beckman Access,
Beckman Coulter Inc., Fullerton, CA, USA). The intra-
assay and interassay coefficients of variation were 4.1%
and 5.2%, respectively. Serum TRACP 5b level was mea-
sured by a solid phase immunofixed enzyme activity
assay (Rat TRACP™ Assay, IDS Inc., Fountain Hills,
AZ, USA) according to the manufacturer’s instructions
to assess bone resorption. The intra- and inter-assay
variations of this measurement in our laboratory were
4.9% and 7.3%, respectively.
Statistical analysis
Results of all measurements were presented as mean ±
S.D. for eight rats in each group. A one-way analysis of
variance (ANOVA) was first performed to determine
whether there were statistically significant (p < 0.05) dif-
ferences among the experimental groups. Further, the
Duncan’s multiple range post-hoc test was used for
comparisons between individual groups and to deter-
mine which means differed statistically significantly (p <
0.05). Pearson’correlation was applied to determine the
correlation between markers of bone turnover and BMD
of the femur and lumbar vertebrae. Correlations were
considered statistically significant at p < 0.05. Data ana-
lysis was performed with SPSS version 13.0 (Chicago,
IL, USA).
Results
Body weight
The rats were weighed weekly throughout the whole
experiment. The initial weights and final weights are
shown in Table 1. At the beginning and end of the pro-
tocol, there was no difference in weight between con-
trols and smoke-exposed female rats (p > 0.05). All
animals increased their weight during the experiment.
The body weight gain of rats receiving passive smoking
during the 2, 3, 4-month experimental period was simi-
lar to that noted in the control groups. The smoke
exposure had no effect on the body weight of rats.
Though individual food intake was not measured, total
food supply in smoke-exposed groups was similar to
that in the control groups. All animals in each group
survived throughout the experiment and they showed
no obvious clinical signs of morbidity.
Blood nicotine concentrations
The blood nicotine concentrations in the 2-month, 3-
month and 4-month smoke-exposed rats were 35.8 ± 6.7
ng/mL, 41.7 ± 6.5 ng/mL and 40.6 ± 5.9 ng/mL, respec-
tively. The concentrations in their controls were 0.7 ±
0.5, 1.2 ± 0.9, 2.4 ± 1.3 ng/mL. The blood nicotine con-
centrations in the smoke-exposed rats were significantly
higher than those in controls (p < 0.01) (Figure 1).
Bone density characteristics
BMD of the lumbar vertebrae and femur are demon-
strated in Figure 2. There was no significant difference
between the lumbar spine BMD at 2-month or 3-
month, but the lumbar spine BMD in the 4-month
smoke-exposed rats was significantly lower than that in
controls (p < 0.01) (Figure 2). Similarly to the lumbar
spine, these data on the femur BMD did not differ sig-
nificantly at 2-month or 3-month, but the BMD of the
femur was significantly lower in the smoke-exposed rats
at 4 months (p < 0.01) (Figure 2). Smoke exposure
resulted in a decrease in the lumbar spine BMD by
11.8% and the femur BMD by 10.5% after 4 months,
respectively, compared to control.
Table 1 Initial and final weights in the controls and
smoke-exposed rats.
Group initial weights(g) final weights(g)
2-month smoke-exposed rats 270 ± 23 286 ± 31
controls (2-month) 271 ± 28 291 ± 26
3-month smoke-exposed rats 280 ± 16 306 ± 27
controls (3-month) 271 ± 25 318 ± 29
4-month smoke-exposed rats 283 ± 17 344 ± 28
controls (4-month) 272 ± 26 362 ± 22
Values are means (for 8 rats) with their standard deviation.
Figure 1 Blood concentrations of nicotine. Significantly higher
blood nicotine concentrations were noted in the smoke-exposed
rats compared to controls. Statistics: means ± SD (8 rats per group),
*p < 0.05 in comparison to controls.
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Figure 3 shows the results of the bone turnover mea-
surements in the controls and smoke-exposed female
rats. There was no significant difference in serum
osteocalcin levels between smoke-exposed rats and
controls (p > 0.05) (Figure 3). There was also no sig-
nificant difference in the serum b-ALP activity and the
TRACP 5b levels between 2-month smoke-exposed
groups and controls(p > 0.05). However, significantly
lower b-ALP activity and higher TRACP 5b levels were
noted in the 3-month or 4-month smoke-exposed rats
compared to controls (p < 0.01) (Figure 3). Smoke
exposure resulted in a decrease in the serum b-ALP
activity by 17.5% and 37.8% after 3 and 4 months,
respectively, compared to control. Furthermore, passive
smoking resulted in a increase in the TRACP 5b by
53.9% and 59.4% after 3 and 4 months, respectively,
compared to control.
Figure 2 Bone mineral density of the lumbar vertebrae and
femur in the controls, 2-month, 3-month and 4-month smoke-
exposed rats. Bone mineral density of the lumbar vertebrae and
femur in the 4-month smoke-exposed rats was significantly lower
than that in controls. Mean ± SD (n = 8 in each group). *p < 0.05
compared to controls.
Figure 3 Levels of osteocalcin, b-ALP and TRACP 5b. There was
no significant difference in serum osteocalcin levels between
controls and smoke-exposed rats. Significantly lower b-ALP and
higher TRACP 5b levels were found in the 3-month or 4-month
smoke-exposed female rats compared to controls. Statistics: means
± SD (8 rats per group), *p < 0.05 in comparison to controls.
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Interestingly, b-ALP positively correlated with BMD of
the lumbar vertebrae (r = 0.764, P = 0.027, Figure 4)
and femur (r = 0.899, P = 0.002, Figure 4) in 4-month
smoke-exposed female rats. Furthermore, TRACP 5b
level negatively correlated with BMD of the lumbar ver-
tebrae (r = -0.871, P = 0.005, Figure 4) and femur (r =
-0.715, P = 0.046, Figure 4) in 4-month smoke-exposed
female rats.
Discussion
Our finding revealed a significant effect of smoking
characteristic on BMD of lumbar spine and femur in
rat, consistent with the results from previous studies
[26,27]. We demonstrated that the BMD of lumbar
s p i n ea n df e m u rw a sl o w e ri n4 - m o n t hs m o k ee x p o s e d
rats than in controls, but not in the 2-month and 3-
month smoke exposed rats, which may be due to
differences in time of passive smoking. César-Neto et al.
[26] showed that 5-month cigarette smoke inhalation
promoted a reduced bone density. Hapidin et al. [28]
demonstrated that 4 months of nicotine treatment was
detrimental to bone by causing an increase in the bone
resorbing cytokines and cotinine levels and nicotine also
exerted negative effects on the dynamic trabecular histo-
morphometric parameters. Tamaki et al.[29] reported
the impact of smoking on bone status was mainly asso-
ciated with the number of smoking years in elderly men.
Furthermore, Sneve et al.[30] showed that smoking
reduced BMD at the hip, distal and ultradistal forearm
in males, and the effect appeared to be mainly time- but
not dose-dependent.
However, previous investigations also have shown that
the timing of BMD decrease may be associated with the
dose level of smoke exposure. Epping-Jordan et al. [24]
reported the mean blood nicotine concentration for
smokers who smoked 30 cigarettes daily was 40-42 ng/
Figure 4 The correlation between markers of bone turnover and BMD. The b-ALP positively correlated with bone mineral density of the
lumbar vertebrae (r = 0.764, P = 0.027) and femur (r = 0.899, P = 0.002) in 4-month smoke-exposed female rats. TRACP 5b level negatively
correlated with bone mineral density of the lumbar vertebrae (r=-0.871, P = 0.005) and femur (r=-0.715, P = 0.046) in 4-month smoke-exposed
female rats.
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ture increased linearly with greater cigarette consump-
tion. It seems that in the case of high exposure, the
effect of smoking develops very fastly and the exposure
duration needed for developing of a measurable effect of
smoking depends on its intensity. In this study, the
blood nicotine concentrations in the 4-month smoke-
exposed rats were 40.6 ng/ml, indicating that the aver-
age blood nicotine concentration was similar to the
average for heavy smokers. The blood nicotine concen-
tration did not differ among 2, 3 and 4 months, but
there may be a harmful effect of longer smoke exposure
for 4 months. Thus, we considered that the timing of
BMD decrease may be associated with the dose level
and the duration of smoke exposure. We could have
shown a threshold dose if we examined an intermediate
time point. It will be of interest to perform this analysis
in a future study.
The skeleton in rats and humans responded similarly
to mechanical influences, hormones, and other agents
[32]. Therefore, it should be taken into account that the
prevalence of the BMD values noted in the rat model of
smoke exposure might be over-estimated compared to
its prevalence in conditions of human exposure. Fukuda
et al. [33] indicated that the rat may reach maturity in
bone age at 17-21 weeks. They concluded that the rat at
this age may be regarded as corresponding to a human
adult of 18-24 years of age. Therefore, the 3-month-old
rat is equivalent to a 13-year-old human, the 6-month-
old rat corresponds to a 26-year-old human. Hapidin et
al.[34] suggested nicotine administration for 2 months
approximately corresponded to 8 years of smoking in
humans, while 4 months of nicotine administration was
equivalent to 17 years of smoking in humans. Therefore,
our study implicated that continuous exposure to cigar-
ette smoke for 17 years may be harmful to BMD of the
human skeleton. That is to say, for 26-year-old adult
who smoked 30 cigarettes daily, it will be very possible
for her to have a low BMD at the age about 43.
Previous studies of the effects of smoking on osteocal-
cin have also produced conflicting results, possibly
because the number of subjects studied has been rela-
tively small[35-37]. Nielsen et al. [35] and Tamaki et al.
[29] reported that there was no effect of smoking on
osteocalcin in humans. Ortego-Centeno et al. [36] and
Supervia et al. [37] found that there were no different
values of serum osteocalcin between smokers and non-
smokers in studies with young men. Gürlek et al. [38]
indicated that osteocalcin levels in smoker patients was
lower than the controls. Reduced serum osteocalcin
levels have also been reported in early postmenopausal
women who smoked[39]. The data on effect of smoke
exposure on osteocalcin in rats are completely lacking.
In this study, smoking did not seem to decrease
osteocalcin level in rats, consistent with the results of
previous report[29,35-37]. It remains unclear why the
osteocalcin level was not decreased during the whole
smoke exposure, in spite of decreased activity of b-ALP
in serum.
The document on the effect of smoke exposure on b-
ALP or TRACP 5b are very rare. Broulik et al.[40]
reported nicotine-induced bone loss was associated with
high bone turnover in the male rats as expressed by
increased b-ALP and TRACP. Supervia et al [37]
reported there were no effect of smoking on serum
TRACP. We demonstrated that smoke exposure
decreased activity of b-ALP and increased the level of
TRACP 5b, suggesting that smoking inhibited bone for-
mation and increased bone resorption. Our findings
about TRACP 5b, which had a low diurnal variability
and varied significantly with time of smoke exposure in
female rats, would indicate that passive smoking can
increase osteoclast activities. Increased rate of bone
turnover with the rate of bone resorption exceeding that
of bone formation can lead to bone loss. In addition, b-
ALP positively correlated with BMD of the lumbar ver-
tebrae and femur in 4-month smoke-exposed female
rats. Furthermore, it is also of interest that changes in
TRACP 5b levels negatively correlated with BMD of the
femur and lumbar vertebrae in 4-month smoke-exposed
female rats. These results suggest that the hazardous
effect of smoking on bone status is associated with
increased bone turnover in female rat. Our finding
revealed the peak of BMD at the femur and lumbar ver-
tebrae was achieved later than that of b-ALP or TRACP
5b. Thus, the smoking effect on BMD might be seen
even when value for the signal-to-noise ratio of BMD is
lower than those of b-ALP or TRACP 5b.
While many studies had focused on the hazardous
effects of smoking on the skeleton, there was little direct
evidence regarding which substance in cigarette exerted
this effect. The major components of the smoke may
affect the skeleton included carbon monoxide [41], nico-
tine[14] and other toxic components of cigarettes[42-45]
(e.g., Cadmium, Lead, Chromium, Benzo(a)pyrene,
dimethylbenz(a)anthracene). Loder et al.[41] reported
that the incidence of congenital spinal deformations was
directly related to carbon monoxide dose. In a previous
study, nicotine given in the drinking water for 3 months
was found to lower BMC in male mice [14]. Syversen et
al.[46]showed that female Sprague Dawley rats were
exposed to nicotine vapour for 2 years and there was no
difference in BMD between control rats and nicotine-
exposed rats. Berley et al.[47] and Yamano et al.[48]
indicated that systemic nicotine may have a significant
adverse impact on bone wound healing and inhibit the
bone matrix-related gene expressions required for
wound healing. Brzóska et al. [42,43] indicated that low
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and biomechanical properties of growing bone, thus
increasing the risk of fractures. Sankaramanivel et al.[44]
revealed that a significant increase in the concentration
of Chromium can decrease bone formation rate. Benzo
(a)pyrene (BaP) and 7,12-dimethylbenz(a)anthracene
(DMBA) are polycyclic aromatic hydrocarbons (PAHs)
found in the tar fraction of cigarette smoke. According
to Lee et al. [45], BaP and DMBA can cause a loss of
bone mass and bone strength, possibly through an
increase in bone turnover. Their results revealed that
BaP and DMBA, two PAHs found in the tar fraction of
cigarette smoke, may be in part responsible for the
adverse effect of cigarette smoking on the bone[45].
Previous studies found that passive smoking caused
some 8 percent of 18,000 female deaths and 1 percent
of 49,000 male deaths from lung cancer, as well as 9
percent of 34,000 female deaths and 4 percent of 42,000
male deaths from ischemic heart disease[49], which sug-
gests that women are the main victims of passive smok-
ing. We confirmed that passive smoking increased the
risk of bone damage in female rat. Thus, our findings
allow for the conclusion that passive smoking may
increase the risk of bone damage in women.
Female may be more susceptible than male to the dis-
ease caused by tobacco. It is well established that the
bone susceptibility to damage is to a high extent deter-
mined by a gender, and if regarding the bone effect in
men and women the future study should involve both
male and female rats. Furthermore, comparison of
impact of passive smoking on the bones in female rat
with in male rat is also necessary.
Though the study was aimed to investigate the impact
of passive smoking, examining the effects of active
smoking on bone was also valuable. Difficulties existed
in drawing a direct comparison to smoking in humans,
since humans inhale tobacco directly from cigarettes.
Thus, the model used in the present study reflected the
effects of passive cigarette smoking, but not those of
active smoking. Humans may be active smokers or pas-
sive smokers, and we cannot comment on the effects of
active smoking using our model.
In addition, cigarette smoke was composed of many dif-
ferent substance. In this study, the rats were exposed to
whole cigarette smoke and not just to a specific substance
of cigarette alone. We did not demonstrated which kinds
of substance in cigarette exactly exerted the hazardous
effect. Another limitation was a relatively small sample
size in this study. The analyses based on a greater sample
size were necessary for a more definitive conclusion.
Conclusion
In summary, the present study suggests that passive
smoking increases bone turnover and then decreases
b o n em i n e r a ld e n s i t ya n dt h ec h a n g ei nB M Di sa s s o -
ciated with increasing bone turnover in female rat.
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